In summary, the SPOP-SRC-3 axis serves as a crucial regulatory mechanism in breast cancer, with therapeutic interventions aimed at restoring this pathway potentially improving outcomes and overcoming resistance in patients. This evidence concerns the gene SPOP and breast cancer.